The renoprotective effects conferred through edoxaban-induced inhibition of FXa activity in DKD mice were related to amelioration of the expression of PARs and proinflammatory genes (9, 44), and caused a decrease in urinary albumin excretion, plasma cystatin C levels, and mesangial proliferation (9, 44). Here, F10 is linked to diabetic kidney disease.